Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00920062 · ClinicalTrials.gov registry record
Measurement of Recirculation During Venovenous Extracorporeal Membrane Oxygenation (VV ECMO)
A clinical trial, sponsored by Transonic Systems.
- Completed
- Registry status
- 16
- Enrollment target
NCT00920062: Completed study, sponsored by Transonic Systems.
NCT00920062 is a clinical trial that has completed, run by Transonic Systems. The registered enrollment target is 16 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00920062 has completed, sponsored by Transonic Systems.
- COMPLETED
- Registry status
- 16 participants
- Enrollment target
Study Summary
This study is to test the usefulness of ultrasound dilution recirculation measurements in patients receiving venovenous extracorporeal membrane oxygenation as therapy. The ultrasound dilution measurements determine the efficiency of support provided by venovenous extracorporeal membrane oxygenation. At the present time there are no other devices available to make recirculation measurements.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 16 participants |
| Start Date | 2007-06 |
| Est. Completion | 2013-06 |
What the finished NCT00920062 record still lists
NCT00920062 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 16 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT00920062 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00920062 about?
NCT00920062 is a clinical study titled "Measurement of Recirculation During Venovenous Extracorporeal Membrane Oxygenation (VV ECMO)". This study is to test the usefulness of ultrasound dilution recirculation measurements in patients receiving venovenous extracorporeal membrane oxygenation as therapy. The ultrasound dilution measurements determine the efficiency of support provided by venovenous extracorporeal membrane oxygenation....
What is the current status of trial NCT00920062?
This trial is currently completed. The enrollment target is 16 participants. The study started on 2007-06. Estimated completion is 2013-06.
Who is sponsoring clinical trial NCT00920062?
This trial is sponsored by Transonic Systems, which has 12 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02422641 · 16 participants · Phase 2
Prospective Evaluation Of High-Dose Systemic Methotrexate In Patients With Breast Cancer And Leptomeningeal Metastasis
- NCT02851758 · 16 participants · NA
Transplantation of Autologously Derived Mitochondria Following Ischemia
- NCT03291028 · 16 participants
Analysis of Primary and Metastatic Tumors in Patients With Renal Cell Carcinoma and Urothelial Carcinoma
- NCT03425526 · 16 participants · Phase 1
Donor T Cell Therapy in Treating Immunocompromised Patients With Adenovirus-Related Disease
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia